Emmanuel Pinard

2.6k total citations
44 papers, 1.3k citations indexed

About

Emmanuel Pinard is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Biochemistry. According to data from OpenAlex, Emmanuel Pinard has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 11 papers in Biochemistry. Recurrent topics in Emmanuel Pinard's work include Neuroscience and Neuropharmacology Research (15 papers), Amino Acid Enzymes and Metabolism (10 papers) and Neuropeptides and Animal Physiology (8 papers). Emmanuel Pinard is often cited by papers focused on Neuroscience and Neuropharmacology Research (15 papers), Amino Acid Enzymes and Metabolism (10 papers) and Neuropeptides and Animal Physiology (8 papers). Emmanuel Pinard collaborates with scholars based in Switzerland, United States and Italy. Emmanuel Pinard's co-authors include Leo A. Paquette, Edilio Borroni, Daniela Alberati, John A. Murphy, Joseph G. Wettstein, Tingzhong Wang, Frédéric Knoflach, Pari Malherbe, Dominik Hainzl and Paolo Bernardi and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Emmanuel Pinard

44 papers receiving 1.2k citations

Peers

Emmanuel Pinard

CMN

PHARM

Michael A. Letavic United States

Romano Di Fabio Italy

Sridhar R. Vasudevan United Kingdom

Jason Brown United States

Alessandro Piergentili Italy

Wilma Quaglia Italy

Shigenori Ohkawa Japan

Darius P. Zlotos Germany

Frank Brown United Kingdom

Barbara Costa Italy

Michael A. Letavic United States

Emmanuel Pinard

672 ×1.2

662 ×1.7

184 ×0.6

CMN

182 ×1.1

152 ×1.1

PHARM

Citations per year, relative to Emmanuel Pinard Emmanuel Pinard (= 1×) peers Michael A. Letavic

Countries citing papers authored by Emmanuel Pinard

Since Specialization

Citations

This map shows the geographic impact of Emmanuel Pinard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Pinard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Pinard more than expected).

Fields of papers citing papers by Emmanuel Pinard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Pinard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Pinard. The network helps show where Emmanuel Pinard may publish in the future.

Co-authorship network of co-authors of Emmanuel Pinard

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Pinard. A scholar is included among the top collaborators of Emmanuel Pinard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Pinard. Emmanuel Pinard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shahsavar, Azadeh, Peter Stohler, Gleb Bourenkov, et al.. (2021). Structural insights into the inhibition of glycine reuptake. Nature. 591(7851). 677–681. 72 indexed citations

Pinard, Emmanuel, et al.. (2018). Applications of organocatalysed visible-light photoredox reactions for medicinal chemistry. Beilstein Journal of Organic Chemistry. 14. 2035–2064. 108 indexed citations

Pinard, Emmanuel, et al.. (2018). Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A Journey from Lab to Patient. CHIMIA International Journal for Chemistry. 72(7-8). 477–477. 25 indexed citations

Woltering, Thomas J., Wolfgang Wostl, Hans Hilpert, et al.. (2013). BACE1 inhibitors: A head group scan on a series of amides. Bioorganic & Medicinal Chemistry Letters. 23(14). 4239–4243. 43 indexed citations

Alberati, Daniela, Jean‐Luc Moreau, Judith A. Lengyel, et al.. (2011). Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia. Neuropharmacology. 62(2). 1152–1161. 108 indexed citations

Alberati, Daniela, Jean‐Luc Moreau, Roland Mory, Emmanuel Pinard, & Joseph G. Wettstein. (2010). Pharmacological evaluation of a novel assay for detecting glycine transporter 1 inhibitors and their antipsychotic potential. Pharmacology Biochemistry and Behavior. 97(2). 185–191. 15 indexed citations

Malherbe, P., Edilio Borroni, Luca Gobbi, et al.. (2009). Biochemical and behavioural characterization of EMPA, a novel high‐affinity, selective antagonist for the OX₂ receptor. British Journal of Pharmacology. 156(8). 1326–1341. 72 indexed citations

Pinard, Emmanuel, Daniela Alberati, Edilio Borroni, et al.. (2008). Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5134–5139. 18 indexed citations

Alberati, Daniela, Simona Ceccarelli, Synèse Jolidon, et al.. (2006). Design and synthesis of 4-substituted-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of GlyT1 inhibitors: Achieving selectivity against the μ opioid and nociceptin/orphanin FQ peptide (NOP) receptors. Bioorganic & Medicinal Chemistry Letters. 16(16). 4305–4310. 11 indexed citations

10.

Milanesi, Eva, Paola Costantini, Raffaele Colonna, et al.. (2006). The Mitochondrial Effects of Small Organic Ligands of BCL-2. Journal of Biological Chemistry. 281(15). 10066–10072. 62 indexed citations

11.

Alberati, Daniela, Dominik Hainzl, Synèse Jolidon, et al.. (2006). 4-Substituted-8-(1-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with superior pharmacological and pharmacokinetic parameters. Bioorganic & Medicinal Chemistry Letters. 16(16). 4321–4325. 7 indexed citations

12.

Pinard, Emmanuel, Simona Ceccarelli, Henri Stalder, & Daniela Alberati. (2005). Discovery of N-(2-aryl-cyclohexyl) substituted spiropiperidines as a novel class of GlyT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(2). 349–353. 19 indexed citations

13.

Ceccarelli, Simona, Emmanuel Pinard, Henri Stalder, & Daniela Alberati. (2005). Discovery of N-(2-hydroxy-2-aryl-cyclohexyl) substituted spiropiperidines as GlyT1 antagonists with improved pharmacological profile. Bioorganic & Medicinal Chemistry Letters. 16(2). 354–357. 19 indexed citations

14.

Cesura, Andrea M., Emmanuel Pinard, Robert Schubenel, et al.. (2003). The Voltage-dependent Anion Channel Is the Target for a New Class of Inhibitors of the Mitochondrial Permeability Transition Pore. Journal of Biological Chemistry. 278(50). 49812–49818. 86 indexed citations

15.

Büttelmann, Bernd, Alexander Alanine, Anne Bourson, et al.. (2003). 2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(5). 829–832. 18 indexed citations

16.

Büttelmann, Bernd, Alexander Alanine, Anne Bourson, et al.. (2003). 4-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines and 4-(3,4-Dihydro-1H-isoquinolin-2-yl)-quinolines as potent NR1/2B subtype selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(10). 1759–1762. 11 indexed citations

17.

Alanine, Alexander, Anne Bourson, Bernd Büttelmann, et al.. (2003). 1-Benzyloxy-4,5-dihydro-1H-imidazol-2-yl-amines, a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(19). 3155–3159. 21 indexed citations

18.

Gill, R., Alexander Alanine, Anne Bourson, et al.. (2002). Pharmacological Characterization of Ro 63-1908 (1-[2-(4-Hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a Novel Subtype-Selective N-Methyl-d-Aspartate Antagonist. Journal of Pharmacology and Experimental Therapeutics. 302(3). 940–948. 45 indexed citations

19.

Pinard, Emmanuel, Alexander Alanine, Anne Bourson, et al.. (2002). 4-Aminoquinolines as a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 12(18). 2615–2619. 21 indexed citations

20.

Pinard, Emmanuel, Alexander Alanine, Anne Bourson, et al.. (2001). Discovery of (R)-1-[2-Hydroxy-3-(4-hydroxy-phenyl)-propyl]-4-(4-methyl-benzyl)-piperidin-4-ol: A Novel NR1/2B Subtype Selective NMDA Receptor Antagonist. Bioorganic & Medicinal Chemistry Letters. 11(16). 2173–2176. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact